Osaic Holdings
GNCA

Osaic Holdings’s Genocea Biosciences, Inc. GNCA Stock Holding History

Osaic Holdings’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-800
Closed -$2K – 7875
2021
Q3 		$2K Hold
800
– – ﹤0.01% 6954
2021
Q2 		$2K Hold
800
– – ﹤0.01% 6799
2021
Q1 		$2K Buy
+800
New +$2.37K ﹤0.01% 6590

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Osaic Holdings's GNCA Position: Q4 2021 in Review

Osaic Holdings sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2021, closing a stake of 800 shares — an estimated $2K sold.

Osaic Holdings first reported a position in GNCA in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 41 funds tracked by Wall St. Rank hold GNCA as of Q4 2021.

  • Osaic Holdings reported no remaining Genocea Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • Osaic Holdings sold 800 Genocea Biosciences, Inc. shares in Q4 2021, an estimated $2K.
  • Osaic Holdings first reported a position in Genocea Biosciences, Inc. in Q1 2021 and held it in 3 quarters.
  • Osaic Holdings's Genocea Biosciences, Inc. position peaked at $2K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2021.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.